TipRanks
Invesque Inc (TSE:IVQ)
TSX:IVQ
Want to see TSE:IVQ full AI Analyst Report?

Invesque (IVQ) AI Stock Analysis

10 Followers

Top Page

TSE:IVQ

Invesque

(TSX:IVQ)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - Gpt-5.6Sol)
Rating:42Neutral
Price Target:
C$0.13
▲(30.00% Upside)
Action:Reiterated
Date:10/02/26
The score is driven primarily by weak financial performance—sharp TTM revenue collapse, ongoing losses, and negative cash flow—partly offset by meaningful recent deleveraging that reduces balance-sheet risk. Technical signals are mixed with weak momentum, and valuation is constrained by a negative P/E and no dividend yield data.
Positive Factors
Deleveraging
Meaningful deleveraging has materially reduced balance-sheet risk compared with the company’s heavily leveraged 2021–2024 period. Lower debt should improve financial flexibility, reduce exposure to refinancing pressure, and leave more capacity to manage the healthcare property portfolio over the coming quarters.
Negative Factors
Severe revenue contraction
The sharp TTM revenue contraction signals a substantial reduction in the company’s operating scale and weakens the recurring base available to support property expenses, overhead, and financing obligations. Unless reversed, this decline can limit reinvestment and impair the durability of future earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Deleveraging
Meaningful deleveraging has materially reduced balance-sheet risk compared with the company’s heavily leveraged 2021–2024 period. Lower debt should improve financial flexibility, reduce exposure to refinancing pressure, and leave more capacity to manage the healthcare property portfolio over the coming quarters.
Read all positive factors

Invesque (IVQ) vs. iShares MSCI Canada ETF (EWC)

Invesque Business Overview & Revenue Model

Company Description
Invesque Inc. functions as a real estate investment trust primarily focused on the healthcare sector. The company's diverse portfolio encompasses properties dedicated to independent living, assisted living, memory care, skilled nursing, and transi...
How the Company Makes Money
Invesque makes money primarily by owning healthcare-related real estate and generating cash flow from those assets. Key revenue streams typically include (1) rental and lease income from properties leased to operators/tenants under contractual lea...

Invesque Financial Statement Overview

Summary
Financial performance is pressured by a severe TTM revenue decline (~72.9%), sharply deteriorated margins with deeply negative operating/net results, and a shift to negative operating and free cash flow. The main offset is a much more conservative balance sheet after significant deleveraging, but ongoing losses and cash burn keep the score low.
Income Statement
18
Very Negative
Balance Sheet
52
Neutral
Cash Flow
24
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.27M79.44M162.67M188.75M198.03M210.45M
Gross Profit4.28M27.79M59.00M72.41M95.59M90.97M
EBITDA-32.12M-9.72M24.27M-18.83M10.38M49.13M
Net Income-38.59M-31.49M-36.14M-99.24M-42.01M-28.54M
Balance Sheet
Total Assets105.78M130.80M637.22M828.28M1.10B1.30B
Cash, Cash Equivalents and Short-Term Investments10.19M39.26M18.16M10.74M27.58M19.37M
Total Debt6.12M33.52M394.84M588.25M765.46M893.75M
Total Liabilities11.69M36.69M518.05M681.18M865.69M1.01B
Stockholders Equity94.09M94.11M119.17M146.59M231.65M286.26M
Cash Flow
Free Cash Flow-3.24M-14.26M4.40M217.00K5.40M11.11M
Operating Cash Flow-2.66M-11.66M9.27M6.03M11.91M18.68M
Investing Cash Flow141.23M397.12M152.21M132.05M137.49M119.19M
Financing Cash Flow-138.21M-363.91M-154.07M-154.92M-141.19M-152.63M

Invesque Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.10
Price Trends
50DMA
0.12
Positive
100DMA
0.12
Positive
200DMA
0.13
Positive
Market Momentum
MACD
<0.01
Positive
RSI
57.82
Neutral
STOCH
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Positive. The current price of 0.1 is below the 20-day moving average (MA) of 0.14, below the 50-day MA of 0.12, and below the 200-day MA of 0.13, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 57.82 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IVQ.

Invesque Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
C$1.59B9.219.49%0.18%5.14%-43.08%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
65
Neutral
C$43.00M8.843.54%2.08%-0.76%-20.95%
56
Neutral
C$106.40M7.888.51%―-15.23%0.74%
49
Neutral
C$1.47B-34.93-50.22%0.30%8.75%-1098.96%
48
Neutral
C$21.91M9.24-2.50%58.44%-6.17%―
42
Neutral
C$112.37M-2.31-40.58%23.12%-92.36%80.14%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:IVQ
Invesque
0.14
0.01
8.00%
TSE:IEI
Imperial Equities
4.55
1.22
36.80%
TSE:MEQ
Mainstreet Equity
173.13
-14.52
-7.74%
TSE:SVI
Storagevault Canada
4.01
-0.88
-17.93%
TSE:PKT
Parkit Enterprise
7.73
-0.22
-2.77%
TSE:BRE
Bridgemarq Real Estate Services
2.31
-10.39
-81.81%

Invesque Corporate Events

Delistings and Listing ChangesM&A TransactionsShareholder Meetings
Invesque Agrees to Premium-Priced Go-Private Deal Led by Magnetar
Positive
Oct 1, 2026
Invesque Inc. has agreed to a go-private transaction under which a special purpose entity managed by Magnetar Financial LLC will acquire all outstanding common shares not already held by Magnetar-managed funds. Minority shareholders will receive U...
Delistings and Listing ChangesM&A TransactionsShareholder Meetings
Invesque Agrees to Premium-Priced Go-Private Deal Led by Magnetar
Positive
Oct 1, 2026
Invesque Inc. has agreed to a go-private transaction in which a special purpose entity managed by Magnetar Financial will acquire all outstanding common shares not already controlled by Magnetar for US$0.101 per share. This cash offer represents a...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Invesque Sheds Seniors Housing Assets Amid Sharp Revenue Drop
Negative
Aug 12, 2026
Invesque Inc., a North American health care real estate company specializing in assisted living, memory care communities and owner-occupied seniors housing, operates through joint ventures with leading operators and direct ownership of seniors hou...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2026